Standard BioTools Inc. LAB

0.74 0.00 0.00% as of 25 Sep
Market cap
$291.7M
P/E
3.4×
Insider Buys alert about insiders buying in the last 12 month

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Cash and Short Term Investments
187.58 292.87 114.90 165.78 28.45 68.52 58.64 95.40 63.14 59.43
Receivables
13.43 14.74 19.66 17.28 18.32 25.42 18.98 16.65 15.05 14.61
Inventory
19.98 20.74 20.53 21.47 20.83 19.69 13.88 13.00 15.09 20.11
Other current assets
228.41 42.96 — 4.26 4.45 4.02 3.52 2.05 1.53 2.52
Total current assets
454.26 375.88 158.22 208.82 72.07 117.66 96.10 127.11 94.80 96.67
Property, Plant, Equpment (Net)
19.28 22.78 24.19 25.65 28.03 17.53 8.06 8.83 12.30 16.53
Long-Term Investments
25.70 — — 1.00 1.00 1.00 1.00 — — —
Goodwill and Intangible Assets (Total)
— 140.25 107.72 118.85 134.31 146.77 150.31 161.51 172.71 183.91
Long Term Assets (Tax, Deferred)
38.63 0.14 — — — — — — — —
Long-term assets (Other)
3.15 186.98 2.29 3.11 3.69 4.68 5.49 6.21 7.54 9.29
Total non-current assets
113.49 236.46 164.85 181.50 203.15 207.09 168.72 176.54 192.55 209.72
Total Assets
567.75 612.35 323.07 390.31 275.21 324.76 264.81 303.65 287.35 306.40
Notes Payable
— — 54.53 — — — — — — —
Accounts Payable
5.41 5.05 9.24 7.91 10.60 9.22 5.15 4.03 4.21 3.97
Accrued Expenses
29.78 21.44 21.02 9.15 4.92 13.79 5.16 14.47 10.54 4.00
Current Part of Debt
— — 5.00 2.08 6.84 2.97 1.83 — — —
Current Revenue (Deferred)
42.00 13.80 15.22 14.44 15.48 16.39 11.80 11.46 10.24 9.16
Other current liabilities
25.63 20.80 — 29.76 29.08 42.06 24.48 33.56 29.26 25.53
Total current liabilities
108.31 65.90 109.33 43.44 49.57 54.25 32.82 37.58 33.47 29.50
Long Term Debt (Total)
0.30 0.30 3.98 62.81 64.21 54.22 53.82 172.06 195.24 194.95
Non-current Revenue (Deferred)
7.79 39.92 14.28 18.18 24.08 29.03 8.17 6.33 4.96 4.32
Long Term Tax Liability (Deferred)
0.81 1.08 0.84 1.06 4.33 8.70 11.49 13.71 16.92 21.14
Non-current Liabilities (Other)
1.22 7.84 1.07 0.96 0.88 1.33 0.57 1.85 5.83 3.26
Total non-current liabilities
35.16 74.73 50.54 117.08 131.05 131.46 78.38 193.95 222.94 223.66
Total liabilities
143.46 140.62 159.87 160.52 180.62 185.71 111.20 231.53 256.42 253.16
Additional Paid In Capital
1,732.39 1,702.22 860.82 847.01 831.42 815.62 777.77 631.61 531.67 493.44
Preferred Stock (Total)
— — 311.25 311.25 — — — — — —
Common Stock (Net)
0.40 0.40 0.08 0.08 0.08 0.08 0.07 0.05 0.04 0.03
Retained Earnings
(1,260.55) (1,185.65) (1,000.75) (926.10) (736.00) (676.76) (623.64) (558.85) (500.20) (439.48)
Treasury Stock
46.47 46.47 5.98 0.56 — — — — — —
Common Equity (Total)
424.29 471.72 (148.05) (81.47) 94.60 139.05 153.61 72.12 30.94 53.23
Shareholders Equity (Total)
424.29 471.72 163.20 229.79 94.60 139.05 153.61 72.12 30.94 53.23
Shareholders Equity and Liabilities (Total)
567.75 612.35 323.07 390.31 275.21 324.76 264.81 303.65 287.35 306.40
Shares (Common)
386.38 377.53 80.23 79.48 76.92 74.54 69.96 49.34 38.79 29.21
Shares (Preferred)
— 0.00 0.26 0.26 — — — — — —
Shareholders Equity (Tangible)
424.29 471.72 55.49 110.94 (39.71) (7.72) 3.30 (89.39) (141.77) (130.67)
Net Debt
(187.28) (292.57) (105.91) (100.89) 42.60 (11.32) (2.98) 76.66 132.10 135.52
Total Debt
0.30 0.30 8.98 64.89 71.05 57.20 55.65 172.06 195.24 194.95

Fold the line items

In millions of $ except per-share values · columns are period end dates